Diagnosis of heart failure in primary care

Heart failure is a syndrome resulting from a structural or functional cardiac disorder. For a diagnosis of heart failure to be made, there should be symptoms or signs, such as breathlessness, effort intolerance or fluid retention, together with objective evidence of cardiac dysfunction. Heart failure is an increasingly important chronic disease syndrome, associated with poor prognosis, poor quality of life for patients, and high healthcare costs.1 w1 In the general population, where all grades of heart failure are represented, 5 year mortality is around 42%2; however, where the diagnosis is established during a hospital admission, 5 year mortality is between 50–75%,3 w2 although the prognosis has improved in the past 10 years. Studies including objective assessment of left ventricular (LV) function, usually echocardiography, indicate a prevalence of left ventricular systolic dysfunction (LVSD) of 2.9% in patients under 754 and up to 7.5% in 75–84 year olds.w3 In the largest recent prospective evaluation of heart failure in the community, definite heart failure was found in 2.3% (95% confidence interval (CI) 1.9% to 2.8%) of the population, with left ventricular ejection fraction (LVEF) <40% in 41% of cases. However, if the LVEF cut-off was set at under 50% rather than 40%, now advocated in some guidelines, 3.1% (95% CI 2.6% to 3.7%) of people aged 45 or over were defined as having heart failure.5 Estimates on heart failure incidence are less available, and vary from 0.9–2.26 per 1000 females (age 45–74) per year and 1.6–4.6 men per 1000 population (age 45–74) per year. Incidence rises rapidly in the elderly, with 1% of men per year developing heart failure after 75 and almost 2% per year in the over 85s. The typical primary care physician, caring for 2000 patients, is likely to have 40–50 patients with heart failure (more …

[1]  M. Packer,et al.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.

[2]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[4]  Mark A. Hlatky,et al.  Guidelines for the Evaluation and Management of Heart Failure Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) , 1995 .

[5]  J. Zamora,et al.  Accuracy of B‐type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: A systematic review , 2006, European journal of heart failure.

[6]  Lucas M Bachmann,et al.  Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. , 2006, Archives of internal medicine.

[7]  M. Davies,et al.  Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). , 2007, European heart journal.

[8]  Eva Pietrzak,et al.  A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. , 2004, Archives of internal medicine.

[9]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[10]  C D Morgan,et al.  The accuracy and interobserver agreement in detecting the 'gallop sounds' by cardiac auscultation. , 1998, Chest.

[11]  M David Tilson,et al.  The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease. , 2005, Circulation.

[12]  A. Hoes,et al.  Classification of heart failure in population based research: An assessment of six heart failure scores , 1997, European Journal of Epidemiology.

[13]  J. Hampton,et al.  Evidence of inadequate investigation and treatment of patients with heart failure. , 1994, British heart journal.

[14]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[15]  S G Thompson,et al.  Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.

[16]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[17]  P Barton,et al.  Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. , 2009, Health technology assessment.

[18]  J. Marving,et al.  Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. , 1989, European heart journal.

[19]  M. Davies,et al.  Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations , 2002, BMJ : British Medical Journal.

[20]  K. Khunti,et al.  Accuracy of a 12‐lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta‐analysis , 2004, European journal of heart failure.

[21]  A. Khasnis,et al.  Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea , 2004 .

[22]  N. Freemantle,et al.  The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.

[23]  R. Lancashire,et al.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study , 2001, The Lancet.

[24]  Roberto Cardarelli,et al.  B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians. , 2003, The Journal of the American Board of Family Practice.

[25]  J. Colquitt,et al.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. , 2009, Health technology assessment.

[26]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[27]  J. Wisnivesky,et al.  The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic review , 2007, BMC emergency medicine.

[28]  R. J. Harman,et al.  National Institute for clinical excellence preoperative tests: Is the consensus hard to get?: 1AP3-9 , 2007 .

[29]  S. Ball,et al.  Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators. , 1998, European heart journal.

[30]  M. Connock,et al.  Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.

[31]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[32]  Perry M. Elliott,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[33]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[34]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[35]  D. Mant,et al.  Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey , 1999, BMJ.

[36]  J. McMurray,et al.  Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction , 1996, BMJ.

[37]  R. Gillum,et al.  Epidemiology of heart failure in the United States. , 1993, American heart journal.

[38]  M. Pfisterer,et al.  Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. , 2004, The New England journal of medicine.